Our transcriptomic analyses of CM-treated HOSEs uncovered gene-expression profiles defining responses to cancer-like TME, highlighted by STAT1, ISG15, and OAS1 in HOSE1C and ITGA2, GREM1, and CDH13 in HOSE2C. This evidence concerns the gene GREM1 and cancer.